Drug Shortage Report for FUROSEMIDE SPECIAL

Last updated on 2022-04-13 History
Report ID 125156
Drug Identification Number 00401633
Brand name FUROSEMIDE SPECIAL
Common or Proper name FUROSEMIDE SPECIAL
Company Name SANDOZ CANADA INCORPORATED
Market Status DORMANT
Active Ingredient(s) FUROSEMIDE
Strength(s) 250MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 25 ML 10LIVI CA
ATC code C03CA
ATC description HIGH-CEILING DIURETICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-09-25
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2022-04-13
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2022-04-13 French Compare
v17 2022-04-13 English Compare
v16 2022-02-17 French Compare
v15 2022-02-17 English Compare
v14 2021-09-28 French Compare
v13 2021-09-28 English Compare
v12 2021-06-28 French Compare
v11 2021-06-28 English Compare
v10 2021-04-20 French Compare
v9 2021-04-20 English Compare
v8 2021-02-01 French Compare
v7 2021-02-01 English Compare
v6 2021-01-25 French Compare
v5 2021-01-25 English Compare
v4 2020-12-07 French Compare
v3 2020-12-07 English Compare
v2 2020-09-28 French Compare
v1 2020-09-28 English Compare

Showing 1 to 18 of 18